Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Interest rates are still high

Stocks on both sides of the border have wilted in this short trading week. Stocks have since suffered after the Bank of Canada said this week that it would hold its key interest rate at 5 per cent , a 22-year high. The rate pause is in line with economist expectation...
Jonathon Brown | September 7, 2023 |

Buzz on the Bullboards: Fail to the chief

It has been an unprecedented week, as focus on major stories related to the financial sector’s struggles and the volatility among crude stocks after OPEC+ said it was slashing output by 1.16 million barrels per day. All eyes were on former President Donald...
Jonathon Brown | April 6, 2023 |

Disruptive. Transformative. Empowering. Integrated Digital Care for the Future.

CareSpan Health Inc. ( TSX-V.CSPN , Forum ) is a disruptive, transformative, and empowering company providing a digital healthcare platform that integrates digital care tools, capabilities, and data in one place. The company's proprietary "Clinic-in-the Cloud" is a c...
Dave Jackson | January 24, 2022 |

Varta, Rock Tech Lithium, Millennial Lithium - all signs point to growth

ON THE AUTHOR: Carsten Mainitz The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research. Most r...
Carsten Mainitz | March 23, 2021 |

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...
Featured Submission | March 18, 2021 |

Will Fed‘s Cap On Interest Rates Trigger Gold’s Rally?

Last week, the FOMC released the minutes from its last meeting. What implications do they carry for the gold market? FOMC Finally Acknowledges the Situation As Serious Last week, the FOMC has published minutes of its meeting from April 28-29. They show that the Fed...
Arkadiusz Sieron | May 27, 2020 |

The Inflation–Deflation Conundrum

As I sit here on the shores of lovely Lake Scugog, its weed-infested waters lying in wait for countless unsuspecting propellers soon to be ensnared, I am reminded of the failed world of central banking and policy initiatives, which too has become ensnared in flora of its ...
Streetwise Reports | May 27, 2020 |

Weimar Fed in the Twenty-First Century

I was pacing around the house this lovely but cold Friday afternoon (after finally having the water supply restored after our well filed for unemployment benefits), trying desperately to think of a topic to write about in this weekly missive, when it suddenly occurred t...
Streetwise Reports | May 15, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...
Streetwise Reports | March 26, 2020 |
1 2 3